Atreca Inc (BCEL) has released an update to notify the public and investors about its officers.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
As Atreca, Inc. scales down operations, Dr. Tito A. Serafini and Dr. Stephen E. Gould have stepped down from their executive roles as Chief Strategy Officer and Chief Scientific Officer, respectively. Both executives have entered into Separation and Consulting Agreements with the company, entitling them to severance payments, continued insurance coverage, and equity vesting, in addition to consultancy roles with capped weekly fees. These agreements also include clauses for release of claims, confidentiality, non-disparagement, and cooperation with Atreca, Inc.
For further insights into BCEL corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.